Depression, Generalized Anxiety Disorder (GAD), Panic Disorder Mental and Behavioural Disorders Depressive episode, unspecified
Conditions
Interventions
Examining the effectiveness of therapist-assisted Internet-based CBT. Participants are selected for each program based on symptom levels.
The interventions are titled GAD Online, Depre
Sponsors
University of Regina (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Resident of Saskatchewan 2. Aged 18 years or older, either sex 3. Currently experiencing symptoms of depression, generalized anxiety, or panic 4. Has regular access to a computer, Internet, and printer 5. Comfortable using the internet and writing e-mails 6. For panic: PHQ-9 - score of 5 or above 7. Generalized Anxiety Disorder (GAD)-7 score of 5 or above 8. Panic Disorder Severity Scale (PDSS) score of 6 or above
Exclusion criteria
Exclusion criteria: 1. Not a resident of Saskatchewan 2. Less than 18 years of age 3. Has no regular access to a computer, internet, and use of printer 4. Currently receiving psychotherapy elsewhere or in some other form 5. Started a new psychotropic medication within the past month or had a change in dosage 6. Meets criteria for current substance abuse or dependence (drugs or alcohol) 7. Meets current criteria for a psychotic disorder or bipolar disorder, or severe symptoms of depression, including frequent suicidal ideation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Depression Anxiety Stress Scale-21 Item (DASS) 2. Patient Health Questionnaire- 9 Item (PHQ-9) 3. Generalized Anxiety Disorder ? 7 (GAD-7) 4. Panic Disorder Severity Scale (PDSS) Measured at baseline, during the study treatment (after the 6th module), at the end of treatment (after the final module) and at 3 months after completing the 12 modules. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. World Health Organization Quality of Life Assessment BREF (WHOQOL-BREF) 2. Work and Social Adjustment Scale (WSAS) 3. Treatment Satisfaction questions 4. Therapeutic Alliance Questionnaire (TAQ) Measured at baseline, during the study treatment (after the 6th module), at the end of treatment (after the final module) and at 3 months after completing the 12 modules. | — |
Countries
Canada
Outcome results
None listed